189 related articles for article (PubMed ID: 16296664)
1. Leukotriene receptor antagonists--an update.
Drug Ther Bull; 2005 Nov; 43(11):85-8. PubMed ID: 16296664
[TBL] [Abstract][Full Text] [Related]
2. Leukotrienes: their role in the treatment of asthma and seasonal allergic rhinitis.
Banasiak NC; Meadows-Oliver M
Pediatr Nurs; 2005; 31(1):35-8. PubMed ID: 15794321
[No Abstract] [Full Text] [Related]
3. Leukotriene-receptor antagonists.
Lipworth BJ
Lancet; 1999 Jan; 353(9146):57-62. PubMed ID: 10023966
[TBL] [Abstract][Full Text] [Related]
4. [Leukotriene antagonists--do they have a value?].
Stey C
Praxis (Bern 1994); 2000 Mar; 89(14):586-90. PubMed ID: 10815466
[TBL] [Abstract][Full Text] [Related]
5. Update on montelukast and its role in the treatment of asthma, allergic rhinitis and exercise-induced bronchoconstriction.
Storms W
Expert Opin Pharmacother; 2007 Sep; 8(13):2173-87. PubMed ID: 17714069
[TBL] [Abstract][Full Text] [Related]
6. Montelukast and zafirlukast in asthma.
Drug Ther Bull; 1998 Sep; 36(9):65-8. PubMed ID: 10194869
[No Abstract] [Full Text] [Related]
7. Leukotriene receptor antagonists in the treatment of allergic rhinitis.
Maynard ML; Ernst ME
Ann Pharmacother; 2001 Oct; 35(10):1274-7. PubMed ID: 11675859
[TBL] [Abstract][Full Text] [Related]
8. [Leukotriene antagonist. All around talent in asthma and allergies].
MMW Fortschr Med; 2002 Nov; 144(47):64. PubMed ID: 12532531
[No Abstract] [Full Text] [Related]
9. Leukotriene receptor antagonists are ineffective for severe atopic dermatitis.
Silverberg NB; Paller AS
J Am Acad Dermatol; 2004 Mar; 50(3):485-6. PubMed ID: 14988703
[No Abstract] [Full Text] [Related]
10. The emerging role of leukotriene antagonists in asthma therapy.
Lipworth BJ
Chest; 1999 Feb; 115(2):313-6. PubMed ID: 10027422
[No Abstract] [Full Text] [Related]
11. Montelukast in general pediatric practices.
Ngamphaiboon J
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S348-51. PubMed ID: 16623053
[TBL] [Abstract][Full Text] [Related]
12. New treatments for asthma: the role of leukotriene modifier agents.
Valacer DJ
J Natl Med Assoc; 1999 Aug; 91(8 Suppl):26S-39S. PubMed ID: 12653390
[TBL] [Abstract][Full Text] [Related]
13. Montelukast (singulair) for allergic rhinitis.
Med Lett Drugs Ther; 2003 Mar; 45(1152):21-2. PubMed ID: 12637892
[No Abstract] [Full Text] [Related]
14. [Reflections on antileukotrienes].
Naberan Toña KX; Martínez González A; Mendia JL
Aten Primaria; 2002 Apr; 29(6):356-8. PubMed ID: 11996716
[No Abstract] [Full Text] [Related]
15. Taking a look at new advances in asthma therapy.
Anderson P
Community Nurse; 1999 Jun; 5(5):19-20. PubMed ID: 10513546
[No Abstract] [Full Text] [Related]
16. Montelukast in guidelines and beyond.
Bousquet J; Demoly P; Humbert M
Adv Ther; 2009 Jun; 26(6):575-87. PubMed ID: 19562275
[TBL] [Abstract][Full Text] [Related]
17. Asthma pharmacotherapy: an update on leukotriene treatments.
Trinh HKT; Lee SH; Cao TBT; Park HS
Expert Rev Respir Med; 2019 Dec; 13(12):1169-1178. PubMed ID: 31544544
[No Abstract] [Full Text] [Related]
18. Leukotriene inhibitors in the treatment of allergy and asthma.
Scow DT; Luttermoser GK; Dickerson KS
Am Fam Physician; 2007 Jan; 75(1):65-70. PubMed ID: 17225706
[TBL] [Abstract][Full Text] [Related]
19. Antileukotrienes and asthma: alternative or adjunct to inhaled steroids?
Kavuru MS; Subramony R; Vann AR
Cleve Clin J Med; 1998; 65(10):519-26. PubMed ID: 9830785
[TBL] [Abstract][Full Text] [Related]
20. Where do leukotriene modifiers fit in asthma management?
Janson S; Lazarus SC
Nurse Pract; 2002 Apr; 27(4):19, 23-4, 26-9; quiz 30-1. PubMed ID: 11984416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
